公司资料
Indivior 股价、新闻与催化剂
- 股票代码:
- INDV
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United Kingdom and listed in the U
股票表现
39.08 USD (+0.18%)
收盘价
最后更新: 2026年8月17日
3.98B USD
市值
股价为何变动
As of Aug 17, 2026, INDV was little changed and closed at $39.08. No new same-company headline was identified in the current news window.
公司概览
Addiction Medicine
Indivior develops and commercializes medicines for substance-use disorders. Its strategy emphasizes long-acting formulations that support sustained treatment while reducing the burden and diversion risks associated with daily medication.
SUBLOCADE Franchise
SUBLOCADE is a monthly extended-release buprenorphine injection for opioid-use disorder and is the company’s primary commercial product. The formulation is administered by healthcare professionals and provides continuous buprenorphine exposure over the dosing interval.
Focused Portfolio Strategy
Indivior is concentrating resources on its marketed addiction franchise after deciding not to internally advance INDV-2000 and not to pursue Phase 3 development of INDV-6001. It retains potential U.S. commercial rights to a future viable product developed by the INDV-6001 licensor.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。